2025 Approvals
What is it prescribed for? BLUJEPA is prescribed for the treatment of female adults and pediatric patients 12 years of age and older (weighing at least 40 kilograms, or 88 pounds) with uncomplicated urinary tract infections (uUTIs) caused by certain bacteria, including Escherichia coli, Klebsiella pneumoniae, Citrobacter freundii complex, Staphylococcus
2025 Approvals
What is it prescribed for? ROMVIMZA is prescribed for adults with symptomatic tenosynovial giant cell tumor (TGCT) also known as Giant Cell Tumor of the Tendon Sheath, where surgery is likely to cause worsening functional problems or serious harm . What is the name of the drug and what does it
Health and Medical Research News
Autism is a developmental condition that affects communication, social interaction, and behavior. Its rates have been rising worldwide, which has led researchers to look at both genetic and environmental factors. One question is whether a mother’s diet—especially folic acid intake during pregnancy—can play a role in lowering
Cancer
Endometrial cancer—also known as uterine cancer—is one of the most common cancers in women. Cases are rising around the world, but survival is improving thanks to early detection and modern treatments. In this video, we break down a 2024 review published in Cancers by Baker-Rand and Kitson.
FDA
For Immediate Release: September 09, 2025The U.S. Department of Health and Human Services and the Food and Drug Administration today announced sweeping reforms to rein in misleading direct-to-consumer pharmaceutical advertisements. Today, the FDA is sending thousands of letters warning pharmaceutical companies to remove misleading ads and issuing approximately 100
Health and Medical Research News
Cataracts are a leading cause of blindness worldwide, and while surgery is effective, it isn’t always affordable or accessible. A new 2024 review in Annals of Translational Medicine highlights promising research into non-surgical treatments—including compounds that may dissolve the protein clumps th
FDA
Nicotine pouches can be dangerous to children if they use, touch, chew on, or eat them. These small fiber pouches, which contain nicotine that is chemically synthesized or derived from the tobacco leaf, can cause nicotine poisoning in children. It’s important to keep these products away from kids and
Cancer
Endometrial cancer (cancer of the lining of the uterus) is one of the most common cancers in women worldwide. Cases are rising, partly due to aging populations, obesity, and diabetes. But new advances in prevention, diagnosis, and treatment are offering hope. What is Endometrial Cancer and Why Is It Rising?
FDA
For Immediate Release: September 03, 2025The U.S. Food and Drug Administration today introduced the Rare Disease Evidence Principles (RDEP) to provide greater speed and predictability in the review of therapies intended to treat rare diseases with very small patient populations with significant unmet medical need and that are driven
FDA
For Immediate Release: September 10, 2025Despite recent declines, opioids remain commonly prescribed to about 1 in 5 U.S. adults who live with chronic pain as effective alternatives are limited. As part of its broader strategy to address the opioid crisis, the U.S. Food and Drug Administration today issued
Diabetes
What Did the Research Discover? This study explored whether stopping metformin therapy—particularly for reasons unrelated to kidney dysfunction—was linked to an increased risk of developing dementia. Researchers analyzed data from Kaiser Permanente Northern California, following over 41,000 metformin users for up to 24 years. The findings revealed
Health and Medical Research News
A new 2024 study in Frontiers in Oncology looked at sacituzumab govitecan, a targeted therapy for triple-negative breast cancer (TNBC)—a fast-growing cancer with fewer treatment options. Already FDA-approved, this drug continues to show promising results, even in real-world settings, for women who’v